Status:
UNKNOWN
The Role of the Device Operating Under the Continuous Positive Airway Pressure in the Recovery Process of Cochlea
Lead Sponsor:
Mirjana Grebenar Cerkez
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
25-79 years
Phase:
NA
Brief Summary
Hypothesis: Patients with obstructive sleep apnea syndrome (OSAS) have cochlear receptor cells damage because of prolonged, recurrent hypoxia. The use of devices operating under the continous positive...
Detailed Description
The participants will be divided in two groups: target (n45) and control group (n32). The target group will consist of patients with OSAS who have been previously examined by a neurologist for sleep d...
Eligibility Criteria
Inclusion
- Patients with OSAS who have been previously examined by a neurologist for sleep disorders, have undergone polysomnography, and have been diagnosed with moderate or severe obstructive sleep apnea according to the AHI index
- Healthy individuals for control group that will consist of subjects in whom specific questionnaires excluded the existence of obstructive sleep apnea.
Exclusion
- age less than 18 years,
- persons with previous neurootological diseases that required surgical treatment
- persons who deviate from the research protocol.
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05362890
Start Date
May 2 2022
End Date
November 1 2024
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Osijek
Osijek, Croatia